Liver Enzymes and @entity414 in Acute XXXX .

@entity1 @entity712 @entity6571 @entity5906 @entity1002 @entity414
BACKGROUND: @entity712 ( @entity712 ) is defined as the new onset or recurrence of gradual or rapidly worsening signs and symptoms of @entity712 , requiring urgent or emergent therapy. OBJECTIVES: This study attempts to assess the association of liver function tests (LFT) and @entity414 level with in hospital outcome and echocardiography parameters, in @entity1 with acute decompensated @entity712 . @entity1 AND METHODS: A total of 100 @entity1 (aged 16 - 90 years, 60% @entity1 ) admitted with @entity712 were enrolled. LFTs and @entity414 levels were assessed on first day and before discharge, and @entity1 were followed for 3 months. RESULTS: In-hospital outcomes were considered. Mean @entity1002 ( @entity1002 ) was 35% (20 - 45%). Mean @entity414 level was 8.4 mg/dL, significantly higher than chronic HF and normal groups (P < 0.02). Elevated liver enzymes were seen in 52% @entity1 , mostly (87%) in transaminases. Liver enzymes were decreased in 85% @entity1 before discharge. LFT and @entity414 levels were inversely and significantly correlated with @entity1002 on echocardiography (P = 0.02), but not with diastolic parameters. Although there was no significant correlation between @entity414 level and in-hospital mortality, risk of intubation and rehospitalization in 3 months, enzyme levels increased in these groups. Increased @entity5906 transaminase ( @entity6571 level) was associated with inotrope infusion in @entity712 @entity1 (42 vs. 82 mg/dL, P = 0.03). CONCLUSIONS: Abnormal transaminases and @entity414 levels are seen in @entity712 @entity1 . Increased @entity6571 levels may be a predictor of the need for inotrope during hospital course in these @entity1 .
